Orchestra BioMed Holdings, Inc.
OBIO
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Operating Income | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 33.8 | 12.9 | 13.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 20.3 | 7.9 | 10.8 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | |
| Total Operating Expenses | 77.9 | 66.7 | 54.1 | 20.8 | 24.3 | |
| Operating Income | -75.2 | -64.3 | -51.5 | -21.8 | -18.8 | |
| Net Income | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Interest Income | 0.7 | 3.4 | 3.8 | 0.0 | 0.3 | |
| Interest Expense | 0.6 | 0.0 | 0.0 | 0.9 | 0.0 | |
| Other Expense | 0.1 | 3.3 | 2.4 | -0.3 | -2.9 | |
| IBT | -75.1 | -61.0 | -49.1 | -23.0 | -21.4 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.9 | 2.6 | |
| Net Income | -75.1 | -61.0 | -49.1 | -23.0 | -21.4 | |
| Per Share Data | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-1.48 | $-0.73 | $-0.68 | |
| EPS Diluted | $0.00 | $0.00 | $-1.48 | $-0.73 | $-0.68 | |
| Shares Outstanding | 38.4 | 36.8 | 33.2 | 31.6 | 31.6 | |
| Diluted Shares Outstanding | 38.4 | 36.8 | 33.2 | 31.6 | 31.6 | |
| Current Assets | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Cash And Equivalents | 23.7 | 22.3 | 30.6 | 9.9 | 20.3 | |
| Short Term Investments | 41.5 | 44.6 | 57.0 | 1.0 | 15.4 | |
| Total Cash & ST Investments | 65.2 | 66.8 | 87.6 | 10.9 | 35.8 | |
| Accounts Receivable | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | |
| Inventory | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Other Current Assets | 1.1 | 2.1 | 1.3 | 0.2 | 0.2 | |
| Total Current Assets | 66.5 | 69.2 | 89.1 | 11.3 | 36.3 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.6 | 3.5 | 2.8 | 1.1 | 1.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 2.5 | 2.5 | 2.5 | 0.4 | 0.2 | |
| Other Long-Term Assets | 0.8 | 1.0 | 0.8 | 0.7 | 0.6 | |
| Total Long-Term Assets | 5.9 | 7.0 | 6.1 | 2.2 | 1.8 | |
| Total Assets | 72.4 | 76.2 | 95.2 | 13.5 | 38.1 | |
| Current Liabilities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Accounts Payable | 6.3 | 5.1 | 2.9 | 2.0 | 1.8 | |
| Short-Term Debt | 0.4 | 0.6 | 1.3 | 2.0 | 4.0 | |
| Other Current Liabilities | 4.2 | 6.1 | 4.5 | 2.7 | 2.8 | |
| Current Liabilities | 14.5 | 16.2 | 11.2 | 12.2 | 14.4 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Long-Term Debt | 1.1 | 16.0 | 1.0 | 3.7 | 5.5 | |
| Capital Leases | 1.1 | 2.2 | 1.7 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 51.5 | 51.5 | |
| Total Liabilities | 28.3 | 43.2 | 27.2 | 84.8 | 86.6 | |
| Total Common Equity | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -278.3 | -309.9 | -248.9 | -166.1 | -143.1 | |
| Comprehensive Income | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 44.1 | 33.0 | 68.0 | -71.2 | -48.5 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Net Income | -55.6 | -61.0 | -49.1 | -23.0 | -21.4 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | |
| Stock-Based Compensation | 9.8 | 10.6 | 7.6 | 0.3 | 0.2 | |
| Change Working Capital | 1.7 | -0.8 | -3.3 | 2.6 | -8.1 | |
| Change In Accounts Receivable | 0.1 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Change In Accounts Payable | 0.9 | 3.0 | 0.1 | 1.1 | -2.6 | |
| Change In Inventories | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Other Non-cash Items | 6.1 | 0.3 | -1.6 | 0.5 | 2.9 | |
| Cash from Operations | -44.6 | 0.0 | -46.1 | -19.4 | -26.2 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.3 | -0.1 | -0.3 | -0.5 | |
| Acquisitions | -46.1 | -0.6 | 0.0 | 0.0 | 0.0 | |
| Investments | -84.9 | -72.6 | -142.0 | -0.2 | -15.6 | |
| Sales of Investment | 147.4 | 86.6 | 152.8 | 13.5 | 43.1 | |
| Other Investing Activities | 52.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 62.4 | 0.0 | 10.7 | 13.0 | 27.0 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Debt Repaid | -10.8 | 0.0 | -10.8 | -4.0 | 0.0 | |
| Debt Issued | 0.7 | 14.8 | 12.5 | 0.2 | 9.5 | |
| Issuance of Common Stock | 0.3 | 0.0 | 0.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -10.7 | 0.0 | 57.1 | 0.0 | 0.0 | |
| Cash from Financing | -10.5 | 0.0 | 46.2 | -4.0 | 10.0 | |
| Nacenění | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| P/E | -1.33 | -2.41 | -6.18 | -4.45 | -8.96 | -12.27 | |
| P/EG | -0.65 | -0.20 | 0.18 | -0.05 | -1.04 | 0.00 | |
| P/B | 348.79 | 4.47 | 4.46 | 2.85 | -2.89 | -5.40 | |
| P/S | 30.77 | 55.83 | 109.91 | 42.34 | -263.60 | 45.93 | |
| P/FCF | -1.65 | -2.90 | -6.57 | -5.01 | -10.46 | -9.80 | |
| P/OFC | -1.66 | -2.91 | -6.58 | -5.11 | -10.61 | -10.01 | |
| Price/EV | -1.11 | -2.21 | -5.36 | -4.37 | -9.34 | -13.49 | |
| Marže | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 94.5% | 92.3% | 93.3% | 90.9% | 125.4% | 97.5% | |
| EBIT Margin | -2,311.8% | -2,437.5% | -1,866.2% | -924.3% | 2,787.6% | -328.8% | |
| EBITDA Margin | -2,311.8% | -2,425.8% | -1,855.8% | -918.1% | 2,764.5% | -326.4% | |
| Operating Profit Margin | -2,311.8% | -2,437.5% | -1,866.2% | -924.3% | 2,787.6% | -328.8% | |
| Net Profit Margin | -2,316.1% | -2,313.3% | -1,779.7% | -951.3% | 2,943.0% | -374.5% | |
| Finanční zdraví | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.10 | 4.27 | 7.95 | 4.56 | 0.92 | 2.52 | |
| Quick Ratio | 2.09 | 4.26 | 7.94 | 4.55 | 0.92 | 2.52 | |
| Solvency Ratio | -0.46 | -1.40 | -1.80 | -0.78 | -0.27 | -0.24 | |
| Cash Ratio | 1.10 | 1.37 | 2.73 | 1.07 | 0.81 | 1.42 | |
| Debt To Assets Ratio | 0.05 | 0.22 | 0.02 | 0.12 | 0.42 | 0.25 | |
| Debt To Equity Ratio | 6.68 | 0.50 | 0.02 | 0.23 | -0.08 | -0.19 | |
| Financial Leverage Ratio | 145.17 | 2.31 | 1.40 | 1.82 | -0.19 | -0.78 | |
| Debt Service Coverage Ratio | -28.51 | 0.00 | 0.00 | 0.00 | -7.70 | -5.30 | |
| Interest Coverage Ratio | -536.86 | 0.00 | 0.00 | 0.00 | -23.52 | 0.00 | |
| Data na akcii | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Revenue Per Share | 0.08 | 0.07 | 0.08 | 0.24 | -0.04 | 0.28 | |
| Net Income Per Share | -1.83 | -1.66 | -1.48 | -2.24 | -1.13 | -1.04 | |
| Cash Per Share | 0.88 | 1.81 | 2.64 | 5.59 | 0.53 | 1.75 | |
| Shareholders Equity Per Share | 0.01 | 0.90 | 2.05 | 3.50 | -3.48 | -2.37 | |
| Free Cash Flow Per Share | -1.57 | -1.38 | -1.39 | -1.99 | -0.96 | -1.31 | |
| Dividend Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Efektivita | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Effective Tax Rate | 0.0% | 0.0% | 0.0% | 0.7% | -4.0% | -12.2% | |
| Receivables Turnover | 31.16 | 28.67 | 27.88 | 36.80 | -6.46 | 33.95 | |
| Payables Turnover | 0.03 | 0.04 | 0.06 | 0.08 | 0.10 | 0.08 | |
| Inventory Turnover | 0.77 | 1.18 | 1.27 | 1.17 | 2.93 | 2.10 | |
| Fixed Asset Turnover | 0.93 | 0.76 | 0.97 | 0.96 | -0.70 | 5.55 | |
| Working Capital Turnover Ratio | 0.07 | 0.04 | 0.04 | 0.11 | -0.07 | 0.00 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
